What does Dr. Simon NJUGUNA & Dr. An DE ROUCK do?

Dr. Simon NJUGUNA & Dr. An DE ROUCK is a specialist medical practice in Affligem. Private Limited, started on 5 January 2023, 1 establishment.

What is the address of Dr. Simon NJUGUNA & Dr. An DE ROUCK?

The registered office of Dr. Simon NJUGUNA & Dr. An DE ROUCK is located at Petterstraat 4, 1790 Affligem.

Is Dr. Simon NJUGUNA & Dr. An DE ROUCK still active?

Yes. According to the CBE (30 September 2026) Dr. Simon NJUGUNA & Dr. An DE ROUCK is active, legal situation “Normale toestand”, started on 5 January 2023.

Is Dr. Simon NJUGUNA & Dr. An DE ROUCK registered on Peppol?

Yes, Dr. Simon NJUGUNA & Dr. An DE ROUCK is registered on the Peppol network with ID 0208:0795803638.

What is the enterprise number of Dr. Simon NJUGUNA & Dr. An DE ROUCK?

The enterprise number of Dr. Simon NJUGUNA & Dr. An DE ROUCK is BE0795803638.

When was Dr. Simon NJUGUNA & Dr. An DE ROUCK founded?

Dr. Simon NJUGUNA & Dr. An DE ROUCK was founded on 5 January 2023.

Who are the directors of Dr. Simon NJUGUNA & Dr. An DE ROUCK?

According to the 2025 annual accounts, the directors of Dr. Simon NJUGUNA & Dr. An DE ROUCK are: Simon NJUGUNA, An DE ROUCK.

Is Dr. Simon NJUGUNA & Dr. An DE ROUCK a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 5 January 2023; 3 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did Dr. Simon NJUGUNA & Dr. An DE ROUCK make in 2025?

Dr. Simon NJUGUNA & Dr. An DE ROUCK posted a profit after taxes of € 63,008 in financial year 2025.

What is the revenue of Dr. Simon NJUGUNA & Dr. An DE ROUCK?

As a small company, Dr. Simon NJUGUNA & Dr. An DE ROUCK is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 106,134.

Dr. Simon NJUGUNA & Dr. An DE ROUCK (Private Limited)

Dossier Dr. Simon NJUGUNA & Dr. An DE ROUCK, printed on 30 September 2026 from databakkes.be/en/0795803638/dr-simon-njuguna-dr-an-de-rouck. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Dr. Simon NJUGUNA & Dr. An DE ROUCK from Affligem, company number BE0795803638, closed financial year 2025 with a result of € 63,008 after tax. For that financial year Dr. Simon NJUGUNA & Dr. An DE ROUCK recorded a gross margin of € 106,134 and equity of € 203,353. Compared with financial year 2024, the result moved from € 109,415 to € 63,008. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 30, 2026.

What it is worth Growing

€ 203,353

▲ 45% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 63,008

▼ 42% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 135,239

▲ 18% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 198,353.

People and assets in 2025

Vehicles and equipment

€ 93,172

▲ 34% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 8 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 115,515

▲ 113% vs 2024

€ 14,203 is repaid this year. At this pace the long-term loan is gone in ≈ 8 years.

Owed to suppliers

€ 7,156

▲ 118% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 7,909

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 42,687 Gross margin 2023: € 42,687 First fiscal year in the series	€ 165,126 Gross margin 2024: € 165,126 ▲ 287% vs 2023 (€ 42,687) Favourable step	€ 106,134 Gross margin 2025: € 106,134 ▼ 36% vs 2024 (€ 165,126) Unfavourable step	▼ 36%
Profit after taxes	€ 25,930 Profit after taxes 2023: € 25,930 First fiscal year in the series	€ 109,415 Profit after taxes 2024: € 109,415 ▲ € 83,485 vs 2023 (€ 25,930) Favourable step	€ 63,008 Profit after taxes 2025: € 63,008 ▼ 42% vs 2024 (€ 109,415) Unfavourable step	▼ 42%
Equity	€ 30,930 Equity 2023: € 30,930 First fiscal year in the series	€ 140,345 Equity 2024: € 140,345 ▲ € 109,415 vs 2023 (€ 30,930) Favourable step	€ 203,353 Equity 2025: € 203,353 ▲ 45% vs 2024 (€ 140,345) Favourable step	▲ 45%
Total debts	€ 73,902 Total debts 2023: € 73,902 First fiscal year in the series	€ 68,147 Total debts 2024: € 68,147 ▼ 8% vs 2023 (€ 73,902) Favourable step	€ 135,650 Total debts 2025: € 135,650 ▲ 99% vs 2024 (€ 68,147) Unfavourable step	▲ 99%
Cash	€ 14,522 Cash 2023: € 14,522 First fiscal year in the series	€ 114,316 Cash 2024: € 114,316 ▲ € 99,794 vs 2023 (€ 14,522) Favourable step	€ 135,239 Cash 2025: € 135,239 ▲ 18% vs 2024 (€ 114,316) Favourable step	▲ 18%
Land & buildings	-	-	€ 23,528 Land & buildings 2025: € 23,528 First fiscal year in the series
Retained profit	€ 25,930 Retained profit 2023: € 25,930 First fiscal year in the series	€ 135,345 Retained profit 2024: € 135,345 ▲ € 109,415 vs 2023 (€ 25,930) Favourable step	€ 198,353 Retained profit 2025: € 198,353 ▲ 47% vs 2024 (€ 135,345) Favourable step	▲ 47%
Bank debt	€ 67,212 Bank debt 2023: € 67,212 First fiscal year in the series	€ 54,143 Bank debt 2024: € 54,143 ▼ 19% vs 2023 (€ 67,212) Favourable step	€ 115,515 Bank debt 2025: € 115,515 ▲ 113% vs 2024 (€ 54,143) Unfavourable step	▲ 113%
Balance sheet total	€ 104,832 Balance sheet total 2023: € 104,832 First fiscal year in the series	€ 208,492 Balance sheet total 2024: € 208,492 ▲ 99% vs 2023 (€ 104,832) Unchanged	€ 339,003 Balance sheet total 2025: € 339,003 ▲ 63% vs 2024 (€ 208,492) Unchanged	▲ 63%

Key figures of Dr. Simon NJUGUNA & Dr. An DE ROUCK, fiscal years 2023 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Dr. Simon NJUGUNA & Dr. An DE ROUCK?

What happened at Dr. Simon NJUGUNA & Dr. An DE ROUCK in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 30, 2026 New annual accounts for financial year 2025: profit of € 63,008 (▼ 42% vs 2024). Source: NBB ↗
Jan 27, 2023 New establishment in Affligem. KBO
2023 Simon NJUGUNA became a director. NBB
2023 An DE ROUCK became a director. NBB
Jan 5, 2023 Start of the company according to the CBE. KBO

In short

From € 25,930 profit in 2023 to € 63,008 profit in 2025.

Paid € 59,330 in corporate taxes since 2023.

Best year ever: 2024, with € 109,415 profit.

Original PDFs at the National Bank ↗

A new publication or filing at Dr. Simon NJUGUNA & Dr. An DE ROUCK? We notify you, reason included.

Follow Dr. Simon NJUGUNA & Dr. An DE ROUCK

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Simon NJUGUNA An DE ROUCK

Dr. Simon NJUGUNA & Dr. An DE ROUCK

Huisartsenvereniging Gent

Behind Dr. Simon NJUGUNA & Dr. An DE ROUCK are Simon NJUGUNA and An DE ROUCK. An DE ROUCK is also behind Huisartsenvereniging Gent.

See the full network in the app

Directors

According to the 2025 annual accounts

Simon NJUGUNA

Director

since 2023

An DE ROUCK

Director

Also active at: Huisartsenvereniging Gent

since 2023

Establishments

Establishment units

Physical locations of this company

Registered office

Petterstraat 4

1790 Affligem

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0795.803.638

VAT number

BE 0795.803.638

Registered office

Petterstraat 4, 1790 Affligem

Names & denominations

Dr. Simon NJUGUNA & Dr. An DE ROUCK

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

5 January 2023

Peppol

Active · Active since 10 Oct 2024

Activities · NACE

Activiteiten van medisch specialisten

Overige zakelijke dienstverlening, neg

View on CBE Public ↗ Annual accounts (NBB) ↗

Dr. Simon NJUGUNA & Dr. An DE ROUCK

Financials

What happened to Dr. Simon NJUGUNA & Dr. An DE ROUCK?

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Management

Directors

Establishments

Establishment units

Details

Frequently asked questions